Bisphosphonates in Children with Osteogenesis Imperfecta may Improve Bone Mineralization but not Bone Strength. Report of Two Patients
Authors:
- E.J.A. RoldánERE.J.A. Roldán
- Τ. PasqualiniΤPΤ. Pasqualini
- L. PlantalechLPL. Plantalech
- 1 January 1999
- journal article
- case report
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 12 (4) , 555-560
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibiaBone, 1998
- Intravenous pamidronate treatment in osteogenesis imperfectaThe Journal of Pediatrics, 1997
- Long-Term Effects of Bisphosphonates on the Growing Skeleton: Studies of Young Patients with Severe OsteoporosisMedicine, 1997
- Stimulation of bone formation by dynamic mechanical loading of rat caudal vertebrae is not suppressed by 3-amino-1-hydroxypropylidene-1-bisphosphonate (AHPrBP)Bone, 1995
- Perspectives: bone's mechanical usage windowsBone and Mineral, 1992
- Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in ratsBone and Mineral, 1990
- Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfectaSkeletal Radiology, 1987